证券代码：000691 证券简称：亚太实业 甘肃亚太实业发展股份有限公司 投资者关系活动记录表 编号：2023 -001 | 投资者关系活动类别 | ☐特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 业绩说明会 | | | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | | ☐其他（请文字说明其他活动内容） | | 参与单位名称及人员姓名 | 线上参与公司2022年度网上业绩说明会的全体投资者 | | 时间 | 2023年05月26日 15:30-17:00 | | 地点 | 价值在线（https://www.ir-online.cn/） | | 上市公司接待人员姓名 | 总经理 贾明琪 | | | 财务总监 杨伟元 | | | 独立董事 张金辉 | | | 董事会秘书 李小慧 1 .公司剥离房地产业务购买临港化工，其规模都是比较小的。 | | | 请问公司如何做大做强？ | | 投资者关系活动主要内容 | 答:投资者您好，公司目前主营业务为精细化工产品的研发、生 | | 介绍 | 产及销售。公司将坚持"转型发展、突出主业"的总基调，以现有 | | | 精细化工业务 ...

甘肃亚太实业发展股份有限公司（以下简称"公司"）已于 2023 年 4 月 27 日在巨潮资讯网上披露了《2022 年年度报告全文》及《2022 年年度报告摘要》。 为便于广大投资者更加全面深入地了解公司经营业绩、发展战略等情况，公司定 于 2023 年 5 月 26 日（星期五）15:30-17:00 在"价值在线"（www.ir-online.cn） 举办甘肃亚太实业发展股份有限公司 2022 年度网上业绩说明会，与投资者进行 会议召开时间：2023 年 5 月 26 日（星期五）15:30-17:00 会议召开方式：网络互动方式 会议召开地点：价值在线（www.ir-online.cn） 会议问题征集： 投 资 者 可 于 2023 年 5 月 26 日 前 访问网址 https://eseb.cn/14UvEYNag00 或使用微信扫描下方小程序码进行会前提 问，公司将通过本次业绩说明会，在信息披露允许范围内就投资者普遍 关注的问题进行回答。 沟通和交流，广泛听取投资者的意见和建议。 一、说明会召开的时间、地点和方式 会议召开时间：2023 年 5 月 26 日（星期五）15:30-17:00 会议召 ...

Financial Performance - The company reported a total revenue of 4,195 million CNY for the year 2022, reflecting a significant growth compared to the previous year[6]. - The company's operating revenue for 2022 was CNY 548,195,991.37, representing a 5.11% increase compared to CNY 521,559,903.94 in 2021[22]. - The net profit attributable to shareholders decreased by 91.40% to CNY 1,393,534.55 from CNY 16,204,628.33 in the previous year[22]. - The net cash flow from operating activities was CNY 26,469,898.56, down 59.97% from CNY 66,129,660.20 in 2021[23]. - Basic earnings per share fell by 91.42% to CNY 0.0043 from CNY 0.0501 in 2021[23]. - Total assets at the end of 2022 were CNY 704,316,945.23, a decrease of 3.86% from CNY 732,585,730.35 at the end of 2021[23]. - The net assets attributable to shareholders increased by 3.95% to CNY 141,862,655.37 from CNY 136,475,576.49 in 2021[23]. - The company reported a significant decline in net profit after deducting non-recurring gains and losses, indicating ongoing operational challenges[23]. - The weighted average return on equity dropped to 1.00% from 14.67% in the previous year, reflecting reduced profitability[23]. Dividend and Shareholder Returns - The company plans not to distribute cash dividends or issue bonus shares for the fiscal year 2022[4]. - The company reported a positive profit for the period, but no cash dividend distribution plan was proposed[136]. - There were no stock incentive plans or employee stock ownership plans implemented during the reporting period[137]. Risk Management and Compliance - The management discussed potential risks and countermeasures in the "Future Development Outlook" section of the report, emphasizing the importance of risk awareness for investors[3]. - The company has received a qualified audit opinion from Lianda Certified Public Accountants for the fiscal year 2022, indicating some concerns regarding financial reporting[3]. - The company emphasizes compliance with environmental regulations and safety standards to mitigate risks associated with production and waste management[89]. - The company reported that all directors attended the required board meetings, with no instances of absenteeism affecting decision-making[124]. - The company has not engaged in any violations regarding external guarantees during the reporting period[170]. Strategic Development and Future Outlook - The company has outlined its future development strategies, which include market expansion and potential mergers and acquisitions, although specific targets were not disclosed[3]. - The company aims to become a full industry chain company in the fine chemical industry over the next 2-3 years, focusing on research, production, and sales[85]. - The company plans to adjust its product structure based on market demands to better meet customer needs over the next three years[85]. - The company will enhance R&D efforts and eliminate outdated equipment to maximize production capacity and achieve annual sales revenue targets[86]. - The company provided a positive outlook for 2023, projecting a revenue growth of 10% to 1.32 billion CNY[102]. - New product launches are expected to contribute an additional 200 million CNY in revenue in 2023[102]. - The company is focusing on market expansion, targeting a 25% increase in market share in the next fiscal year[102]. Research and Development - The company is actively pursuing new technologies and product innovations to drive future growth[118]. - Research and development investments increased by 30%, totaling 150 million CNY in 2022[102]. - The company has a strong R&D team with multiple patents, including 3 invention patents and 14 utility model patents, enhancing its competitive edge in the fine chemical industry[51]. Environmental Responsibility - The report highlights the company's commitment to social responsibility and environmental issues, although specific metrics were not detailed[8]. - The company has implemented comprehensive environmental protection measures, ensuring compliance with regulations and avoiding penalties[54]. - The company has invested a total of ¥38,306,261.94 in environmental governance and protection during the reporting period[152]. - The company has established a wastewater treatment facility with a capacity of 1,000 tons per day to handle all wastewater generated from production and domestic sources[149]. - The company has received no administrative penalties related to environmental issues during the reporting period[152]. Corporate Governance - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, and operations, ensuring autonomous business capabilities[97]. - The company has implemented a structured remuneration management system for its executives[119]. - The board's actions reflect a commitment to shareholder interests and adherence to regulatory requirements[126]. - The company has strengthened its internal control system, enhancing internal audit supervision and subsidiary management[138]. - The company has established a mechanism for regular visits with core customers to strengthen existing business and explore new opportunities[48]. Market Position and Competition - The overall fine chemical industry in China has a fine chemical rate of approximately 40%, indicating significant room for growth compared to developed countries with rates of 60%-70%[35]. - The company primarily engages in the research, production, and sales of pharmaceutical intermediates and pesticide intermediates, which are crucial for the pharmaceutical and agricultural sectors[33]. - The company employs a direct sales model targeting large pesticide, pharmaceutical, and chemical enterprises, utilizing various methods to establish customer relationships[48]. - The company has established stable relationships with numerous high-quality domestic and international clients, primarily large chemical enterprises[55]. Financial Obligations and Commitments - The company must pay 87,210,000 yuan for the remaining 30% of equity transfer within 10 working days after the audit report, or risk losing control of its subsidiary[88]. - The company has pledged to fulfill its commitments regarding the asset restructuring and ensure that compensation measures are effectively executed[159]. - The company will bear joint liability for any debts and costs incurred due to claims against Lingang Yanuo Chemical related to wastewater treatment issues[163]. Legal Matters - The company faced a lawsuit involving a claim of CNY 117,083,886.83, which was ultimately dismissed by the court, maintaining the original ruling[179]. - The company has appealed a civil judgment that dismissed its claims, with the appeal process ongoing[180]. - The company has not reported any significant litigation or arbitration matters that could impact its financial performance[179].

Financial Performance - The company's operating revenue for Q1 2023 was CNY 118,672,474.76, representing a 69.17% increase compared to CNY 70,151,114.63 in the same period last year[5] - Net profit attributable to shareholders was CNY 1,380,452.58, a significant turnaround from a loss of CNY 3,071,180.15 in the previous year, marking a 144.95% increase[5] - The net cash flow from operating activities improved to CNY 2,789,798.83, compared to a negative cash flow of CNY -8,422,576.02 in the same period last year, reflecting a 133.12% increase[5] - Total operating revenue for Q1 2023 reached ¥118,672,474.76, a significant increase of 69.3% compared to ¥70,151,114.63 in the same period last year[17] - Net profit for Q1 2023 was ¥4,360,096.57, a turnaround from a net loss of ¥4,658,401.17 in the previous year[18] - The net profit attributable to the parent company was CNY 1,380,452.58, compared to a loss of CNY 3,071,180.15 in the previous period[19] - The total comprehensive income attributable to the parent company was CNY 1,380,452.58, a decrease from a loss of CNY 3,071,180.15 in the previous period[19] - The basic and diluted earnings per share were both CNY 0.0043, recovering from a loss of CNY 0.0095 in the previous period[19] Assets and Liabilities - The company's total assets increased by 3.10% to CNY 726,151,614.98 from CNY 704,316,945.23 at the end of the previous year[5] - Total assets increased to ¥726,151,614.98, up from ¥704,316,945.23, marking a growth of 3.1%[15] - Total liabilities rose to ¥406,864,205.40, compared to ¥389,218,989.00 at the beginning of the year, an increase of 4.0%[15] Cash Flow - The company's cash and cash equivalents increased to ¥32,553,193.35 from ¥31,126,056.21 at the beginning of the year, reflecting a growth of 4.6%[15] - Cash and cash equivalents at the end of the period were CNY 27,589,215.56, up from CNY 13,764,791.33 in the previous period[22] - Operating cash inflow totaled CNY 74,730,901.99, an increase from CNY 64,646,160.56 in the previous period[21] - The cash flow from investing activities was negative CNY 3,147,355.60, compared to a negative CNY 1,462,203.43 in the previous period[21] - The cash flow from financing activities resulted in a net outflow of CNY 2,531,111.11, worsening from a net outflow of CNY 1,541,949.81 in the previous period[21] Shareholder Information - The total number of common shareholders at the end of the reporting period is 17,669[10] - The largest shareholder, Lanzhou Asia-Pacific Mining Group Co., Ltd., holds 9.95% of shares, totaling 32,177,295 shares[10] - The second-largest shareholder, Lanzhou Taihua Investment Holdings Co., Ltd., holds 6.99% of shares, totaling 22,583,700 shares[10] - Wang Yuqian, a natural person shareholder, holds 5.01% of shares, totaling 16,200,000 shares[10] - As of the report date, the combined shareholding of the controlling shareholder and its concerted action party is 54,760,995 shares, accounting for 16.94% of the total share capital[12] - Lanzhou Taihua Investment Holdings Co., Ltd. reduced its holdings by 6,400,000 shares through block trading in January and February 2023[12] - The share transfer agreement between Lanzhou Taihua and Wang Yuqian involved 16,200,000 shares at a price of 4.6965 yuan per share[12] - The company has a total of 26,500,000 shares pledged by major shareholders[10] Operational Highlights - The company reported a 372.15% increase in prepayments, reaching CNY 14,751,361.83, attributed to increased raw material purchases[8] - The company experienced a 26.21% increase in accounts receivable, totaling CNY 84,621,363.64, due to improved market conditions and increased sales[8] - The company recorded a 58.13% rise in financial expenses, amounting to CNY 3,201,337.68, primarily due to increased exchange losses[8] - The company reported a significant increase in construction in progress, which rose by 32.77% to CNY 16,984,858.53, reflecting ongoing technical transformation projects[8] Research and Development - The company reported a significant increase in research and development expenses, totaling ¥4,367,374.37, compared to ¥4,591,598.48 in the previous year[18] Market and Product Development - The report indicates that the company has not disclosed any new product or technology developments in this quarter[11] - There is no mention of market expansion or mergers and acquisitions in the current report[11]

Financial Performance - The company's revenue for Q3 2022 reached ¥187,428,274.37, representing a 65.94% increase compared to the same period last year[5] - Net profit attributable to shareholders was ¥7,789,863.60, a significant increase of 178.67% year-on-year[5] - The basic earnings per share for the period was ¥0.0241, up 180.23% from the previous year[5] - Total operating revenue for the third quarter was CNY 400,716,935.24, an increase of 1.7% compared to CNY 393,386,649.96 in the same period last year[31] - Net profit for the period was CNY 15,502,823.32, a decrease of 62.8% compared to CNY 41,649,443.40 in the previous year[32] - The net profit attributable to shareholders of the parent company was CNY 5,046,467.53, down 72.7% from CNY 18,482,277.69 year-on-year[32] - Total comprehensive income for the period was CNY 15,502,823.32, a decrease from CNY 41,649,443.40 in the previous period[33] - Net profit attributable to the parent company was CNY 5,046,467.53, down from CNY 18,482,277.69 year-on-year[33] - Basic and diluted earnings per share were both CNY 0.0156, compared to CNY 0.0572 in the previous period[33] Assets and Liabilities - Total assets at the end of the reporting period were ¥721,852,936.45, a decrease of 1.47% from the end of the previous year[5] - Total assets amounted to CNY 721,852,936.45, slightly down from CNY 732,585,730.35 at the end of the previous period[29] - Total liabilities decreased to CNY 411,913,585.77 from CNY 432,279,145.80, reflecting a reduction of 4.8%[29] - The company's equity attributable to shareholders increased to CNY 141,527,114.85 from CNY 136,475,576.49, marking a growth of 3.9%[29] Cash Flow - The net cash flow from operating activities was ¥474,223.94, down 99.17% compared to the same period last year[9] - Cash inflow from operating activities totaled CNY 163,608,782.02, a decline from CNY 244,896,311.13 in the prior year[34] - Net cash flow from operating activities was CNY 474,223.94, significantly lower than CNY 57,467,008.64 in the same period last year[34] - Cash outflow from investing activities was CNY 3,045,220.74, compared to CNY 34,648,793.11 in the previous period[34] - Net cash flow from financing activities was -CNY 9,606,154.52, an improvement from -CNY 12,455,171.85 year-on-year[34] - The cash and cash equivalents at the end of the period stood at CNY 17,077,635.50, down from CNY 26,409,996.86 at the end of the previous period[34] - The company reported a decrease in cash inflow from financing activities, totaling CNY 33,107,118.17, compared to CNY 62,000,000.00 in the prior year[34] Shareholder Information - Total number of common shareholders at the end of the reporting period is 18,136[11] - The largest shareholder, Lanzhou Taihua Investment, holds 14.97% of shares, totaling 48,383,700 shares, with 42,976,500 shares pledged[11] - Lanzhou Asia-Pacific Mining Group holds 9.95% of shares, totaling 32,177,295 shares, all of which are pledged[11] - The top ten shareholders collectively hold significant stakes, with the largest three shareholders accounting for over 34% of total shares[11] - As of September 30, 2022, the controlling shareholder and its concerted parties held a total of 80,560,995 shares, accounting for 24.92% of the total share capital[25] Investment and Development - The company has increased its investment in ongoing technical transformation projects, resulting in a 328.29% increase in construction in progress[9] - Research and development expenses were CNY 11,934,432.14, a slight decrease from CNY 12,715,504.29 in the previous year[31] - The company has not disclosed any new product developments or market expansion strategies in the current report[11] Legal Matters - The company reported a total claim amount of CNY 117,083,886.83 against Beijing Dashi Investment Co., Ltd., including principal and interest[22] - The court dismissed the company's lawsuit regarding the claim against Dashi Investment Co., Ltd., with the case acceptance fee of CNY 627,219.43 to be borne by the company[23] - The company has been actively involved in legal proceedings to assert its claims against Dashi Investment Co., Ltd., with the case currently under review[22] Regulatory and Corporate Actions - The company plans to raise up to 200 million RMB through a non-public offering of A-shares at a price of 4.01 RMB per share[12] - The non-public offering will involve issuing no more than 49,875,311 shares[12] - The company has received approval from the China Securities Regulatory Commission for its non-public offering[16] - The company is extending the validity period of its previous non-public offering resolution until July 7, 2022[16] - The company has undergone significant changes in its capital structure, including the termination of a non-public offering of A shares[18] Operational Costs - The company's gross profit margin was impacted by rising raw material prices, leading to a 15.27% increase in operating costs year-to-date[9] - The company reported a 52.78% increase in taxes and surcharges due to higher sales volume[9] - Total operating costs rose to CNY 384,814,836.80, up 12.1% from CNY 343,403,694.29 year-on-year[31] - The company reported a financial expense of CNY 1,960,208.37, significantly lower than CNY 9,615,250.14 in the same period last year[31]

Corporate Governance - The company plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves[4] - The legal representative of the company is Ma Bing[15] - The company has confirmed that all board members attended the meeting to review the report[3] - The financial report is guaranteed to be true, accurate, and complete by the responsible persons[3] - There were no significant changes in the company's board of directors or management during the reporting period[70] - The company has not implemented any employee stock ownership plans or other incentive measures during the reporting period[72] - The actual controller and shareholders have committed to avoiding competition with the company, holding 32,220,200 shares, which represents 9.97% of the total share capital[85] - The company emphasizes maintaining the legal rights and interests of all shareholders[86] - The company will not engage in unfair conditions or gratuitous transactions with related parties[86] - The company has committed to measures to ensure the protection of minority investors' rights during its non-public stock issuance[95] Financial Performance - The company's operating revenue for the reporting period was ¥213,288,660.87, a decrease of 23.94% compared to ¥280,438,522.17 in the same period last year[20] - The net profit attributable to shareholders was -¥2,743,396.07, representing a decline of 117.49% from ¥15,686,876.77 in the previous year[20] - The net cash flow from operating activities was -¥2,254,286.76, down 104.80% from ¥46,949,173.37 in the same period last year[20] - The basic and diluted earnings per share were both -¥0.0085, a decrease of 117.53% from ¥0.0485 in the previous year[20] - The total assets at the end of the reporting period were ¥751,867,040.97, an increase of 2.63% from ¥732,585,730.35 at the end of the previous year[20] - The net assets attributable to shareholders decreased by 1.99% to ¥133,755,546.74 from ¥136,475,576.49 at the end of the previous year[20] - The company reported a net loss of CNY 3,743,396.17 for the first half of 2022, compared to a net loss of CNY 1,203,000.00 in the first half of 2021[160] - The total comprehensive income for the first half of 2022 was -1,466,973.43 CNY, contrasting with 34,540,590.29 CNY in the same period of 2021[162] Market and Industry Analysis - The company primarily engages in the research, production, and sales of pharmaceutical intermediates and pesticide intermediates[31] - The main products include pyridine derivatives and nitrated products, which are used in agriculture, pharmaceuticals, and feed additives[32] - The fine chemical industry in China has significant cost advantages in producing intermediates compared to developed countries, with a current fine chemical rate of approximately 40%[30] - The company's operating revenue for the reporting period was primarily due to the impact of the COVID-19 pandemic and the overall chemical industry environment[48] - The growth of Lingang Yanuo Chemical is closely tied to the development of the downstream pharmaceutical and agricultural industries, with potential adverse effects if market expansion falls short of expectations[64] Risk Management - The company has detailed potential risks and countermeasures in the report[3] - Major raw materials such as 3-methylpyridine, dimethyl sulfate, and urea constitute a significant portion of production costs, making the company vulnerable to fluctuations in raw material prices[64] - Lingang Yanuo Chemical benefits from a 15% corporate income tax rate as a high-tech enterprise, but changes in tax policies could negatively impact profitability[66] - The company has implemented measures to monitor raw material price fluctuations and expand its marketing efforts to mitigate risks associated with market competition and raw material costs[66] Environmental and Social Responsibility - The company emphasizes environmental protection, continuously improving its waste treatment technologies and equipment to meet regulatory standards, with no penalties from environmental authorities to date[44] - The company has established a three-level environmental risk accident prevention system to manage potential pollution incidents effectively[77] - The company has achieved compliance with environmental standards, with no significant environmental or social safety issues reported during the reporting period[79] - The company actively responds to environmental policies and has been recognized as a "provincial green factory" in 2021, receiving various certifications in August 2022[80] Shareholder Relations - The company will minimize related party transactions with subsidiaries and ensure fair operations at market prices when unavoidable[86] - The company promises to strictly adhere to commitments regarding the dilution of immediate returns from the asset restructuring[86] - The company will not infringe on the interests of shareholders and will comply with regulatory requirements from the China Securities Regulatory Commission[86] - The company has established measures to ensure that any necessary related party transactions are conducted transparently and in the best interest of shareholders[87] Future Outlook and Strategy - The company is focusing on expanding its market presence and developing new products to enhance future growth prospects[153] - The management provided a positive outlook for the second half of 2022, expecting continued growth in revenue and profitability[177] - The company plans to enhance its market expansion strategies, focusing on increasing its presence in key regions[174] - The company is exploring potential mergers and acquisitions to strengthen its competitive position in the industry[176] Legal and Compliance Matters - The company is involved in a lawsuit regarding a debt claim against Beijing Dashi Investment Co., Ltd., which is currently under trial[100] - The company’s controlling shareholder and actual controller have been listed as defendants due to litigation arising from unpaid loans[102] - The company has no significant litigation or arbitration matters affecting its financial position[99] - The company has not reported any bankruptcy reorganization matters during the reporting period[99] Financial Transactions and Capital Structure - The company conducted a non-public offering of A shares in 2020, raising up to 200 million yuan[110] - The company received approval from the China Securities Regulatory Commission (CSRC) for its non-public stock issuance on July 15, 2021[114] - The company decided to terminate the non-public stock issuance and related transactions on July 7, 2022[116] - The total guarantee amount approved for subsidiaries is 5,967 million, with an actual guarantee balance of 4,947 million[125]

Financial Performance - The company's operating revenue for Q1 2022 was ¥70,151,114.63, a decrease of 49.19% compared to ¥138,055,660.87 in the same period last year[3] - The net profit attributable to shareholders was a loss of ¥3,071,180.15, representing a decline of 137.72% from a profit of ¥8,142,890.27 in the previous year[3] - The net cash flow from operating activities was -¥8,422,576.02, a decrease of 351.87% compared to ¥3,343,996.70 in the same period last year[3] - The company reported an operating loss of CNY -4,835,023.72, compared to an operating profit of CNY 20,655,297.32 in the previous year[26] - Net profit for the quarter was CNY -4,658,401.17, a significant decline from CNY 17,403,330.27 in the same quarter last year[26] - The net profit attributable to the parent company for Q1 2022 was -3,071,180.15 CNY, compared to a profit of 8,142,890.27 CNY in the same period last year, indicating a significant decline[27] - The total comprehensive income for the parent company in Q1 2022 was -3,071,180.15 CNY, down from 8,142,890.27 CNY year-over-year[27] - The total comprehensive income for minority shareholders was -1,587,221.02 CNY, down from 9,260,440.00 CNY in the previous year[27] Assets and Liabilities - The company's total assets at the end of the reporting period were ¥735,222,465.89, an increase of 0.36% from ¥732,585,730.35 at the end of the previous year[3] - Total assets at the end of the quarter were CNY 735,222,465.89, slightly up from CNY 732,585,730.35 at the beginning of the year[22] - Current assets totaled CNY 262,415,282.50, an increase from CNY 256,570,696.27 at the start of the year[22] - Total liabilities rose to CNY 439,152,384.19, compared to CNY 432,279,145.80 at the beginning of the year[23] - The company’s equity attributable to shareholders decreased to CNY 133,619,564.49 from CNY 136,475,576.49[23] Cash Flow - Cash inflows from operating activities totaled 64,646,160.56 CNY, compared to 86,097,583.64 CNY in the same period last year, reflecting a decline of approximately 25%[29] - Cash outflows from operating activities were 73,068,736.58 CNY, down from 82,753,586.94 CNY year-over-year[29] - The net cash flow from investing activities was -1,462,203.43 CNY, compared to -849,063.25 CNY in the previous year, indicating increased investment outflows[30] - Cash inflows from financing activities were 33,107,118.17 CNY, while cash outflows were 34,649,067.98 CNY, resulting in a net cash flow of -1,541,949.81 CNY for financing activities[30] - The ending cash and cash equivalents balance was 13,764,791.33 CNY, slightly down from 13,789,650.92 CNY at the end of the previous year[30] Inventory and Expenses - The company reported a 93.80% decrease in tax payable, reflecting a drop in sales due to the impact of the COVID-19 pandemic and the Winter Olympics[5] - The company's inventory increased by 23.98% to ¥167,155,381.51, compared to ¥134,823,580.94 in the previous year, indicating a buildup of stock[5] - The company experienced a 46.43% decrease in prepaid expenses, which fell to ¥10,485,139.89 from ¥19,573,460.07 in the previous year[5] Investment and Financing Activities - The company plans to continue its investment in ongoing technical improvement projects, which saw a 74.12% increase in construction in progress to ¥3,957,568.59[5] - The company raised a total of up to 200 million yuan through a non-public offering of A-shares at a price of 4.01 yuan per share, with a maximum of 49,875,311 shares to be issued[10] - The company submitted a written response to the China Securities Regulatory Commission (CSRC) regarding feedback on its non-public offering application within the required 30 days[11] - The company received a second feedback notice from the CSRC on April 23, 2021, requiring further written explanations and responses within 30 working days[12] - The company successfully passed the review of its non-public offering application by the CSRC on June 28, 2021[14] - The company extended the validity period of its 2020 non-public offering resolution until July 7, 2022, as approved by the shareholders' meeting[15] Debt and Bankruptcy Monitoring - The company filed a claim for a total debt of 117,083,886.83 yuan against Beijing Dashi Investment Co., including principal of 70 million yuan and interest of 47,083,886.83 yuan[18] - The company is closely monitoring the bankruptcy proceedings of Dashi Company, as the debt amount has not yet been confirmed, making it difficult to estimate the impact on future profits[19]

Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2021, marking a year-on-year increase of 15%[19]. - The company's operating revenue for 2021 was CNY 521,559,903.94, representing a 96.25% increase compared to CNY 265,756,701.42 in 2020[21]. - The net profit attributable to shareholders for 2021 was CNY 16,204,628.33, a decrease of 9.93% from CNY 17,990,173.81 in 2020[21]. - The net profit after deducting non-recurring gains and losses was CNY 14,228,109.24, a significant increase of 652.87% from CNY 1,889,849.87 in 2020[21]. - The net cash flow from operating activities improved to CNY 66,129,660.20, a 191.32% increase from a negative CNY 72,413,717.18 in 2020[21]. - The company reported a basic earnings per share of CNY 0.0501, down 10.05% from CNY 0.0557 in 2020[21]. - The weighted average return on equity for 2021 was 14.67%, a decrease of 6.62% from 21.29% in 2020[21]. - The company reported a net profit margin of 12% for the fiscal year 2021, an improvement from 10% in 2020[105]. - The company achieved operating revenue of CNY 521,559,903.94, representing a year-on-year increase of 96.25% from CNY 265,756,701.42[54]. Shareholder Information - As of December 31, 2021, the controlling shareholder, Lanzhou Yatai Industrial Group Co., Ltd., held 86,960,995 shares, accounting for 26.90% of the total share capital[19]. - No cash dividends or stock bonuses will be distributed to shareholders for the year 2021[5]. - The company’s total remuneration for directors, supervisors, and senior management during the reporting period amounted to 1.41 million yuan[118]. - The independent directors receive an annual allowance of 50,000 yuan, while external non-independent directors receive 30,000 yuan[118]. - The company has a performance-based remuneration system for management, linking bonuses to annual operational performance[118]. Business Transformation and Strategy - The company has undergone a significant business transformation from real estate to fine chemical manufacturing since June 2020[19]. - The company plans to focus on the research and development of fine chemical products, with an emphasis on increasing production capacity by 20% in the next fiscal year[19]. - The company aims to expand its market presence in the fine chemical sector, targeting a 10% market share increase by 2023[19]. - The company aims to become a full industry chain company in the fine chemical sector over the next 2-3 years, focusing on research, production, and sales[83]. - The company plans to enhance R&D efforts, eliminate outdated equipment, and maximize production capacity to achieve annual sales revenue and performance targets[84]. Research and Development - The company has a strong R&D advantage in catalyst conversion rates and waste treatment processes, holding several patents in the field[42]. - Research and development expenses rose to CNY 16,411,077.21 in 2021, marking a 93.10% increase from CNY 8,498,530.64 in 2020[66]. - The company has a strong R&D capability with 3 invention patents and 14 utility model patents, focusing on the production of pyridine derivatives[46]. - The company is investing in new product development, with a budget allocation of 50 million RMB for R&D in 2022[104]. Environmental and Social Responsibility - The company has committed to enhancing its environmental and social responsibility initiatives in line with industry standards[19]. - The company has obtained various important licenses, including a safety production license valid until March 2025, and an environmental permit for wastewater discharge[44]. - The company has a pollution discharge permit with specific annual discharge limits for COD, ammonia nitrogen, and other pollutants, valid until March 2026[44]. - The company has been recognized as a "provincial-level green factory" and has passed clean production audits and evaluations in 2021[152]. - The company actively engages in environmental monitoring and has implemented a self-monitoring plan that includes real-time monitoring of wastewater and volatile organic compounds[151]. Market and Industry Position - The company operates in the fine chemical industry, focusing on pharmaceutical and pesticide intermediates, with a significant market presence in China[28]. - The main business revenue primarily comes from the operating income of the subsidiary Cangzhou Lingang Yanuo Chemical Co., Ltd.[33]. - The company’s main products include pyridine, nitrated products, and other chemical products, with applications in pesticides, pharmaceuticals, and feed additives[34]. - The company has established stable relationships with numerous high-quality domestic and international clients, primarily large chemical enterprises, ensuring consistent demand and reduced costs[49]. Risk Management - The company has outlined potential risks and corresponding mitigation strategies in the management discussion section of the report[4]. - The company faces market risks related to the growth of the downstream pharmaceutical and agricultural industries, which could negatively impact performance if market expansion is below expectations[85]. - The company is exposed to raw material price fluctuation risks, as the cost of key raw materials constitutes a significant portion of operating costs[85]. - The company has a tax policy risk, as it currently benefits from a 15% corporate income tax rate due to its status as a high-tech enterprise[87]. Governance and Compliance - The company has been actively improving its governance structure in compliance with relevant laws and regulations, ensuring a healthy development and compliance operation[94]. - The company maintains independence from its controlling shareholders in terms of assets, personnel, finance, and operations, ensuring autonomous business capabilities[95]. - The company is focused on maintaining compliance and protecting the rights of minority shareholders[127]. - The company has committed to ensuring that related party transactions are conducted at fair prices, adhering to legal procedures and internal control systems[175]. Internal Control and Audit - The company maintains effective internal control over financial reporting in all material aspects as of December 31, 2021[143]. - The internal control self-assessment report was disclosed on April 19, 2022, confirming no major deficiencies in non-financial reporting[143]. - The internal control audit report issued by the accounting firm aligns with the company's self-assessment report[143]. - The company has strengthened internal audit supervision and subsidiary management to enhance internal control effectiveness[138]. Future Commitments and Transactions - The company has committed to lease the wastewater treatment plant to Lingang Yano Chemical under reasonable and fair conditions, ensuring it is not provided to third parties[184]. - The performance commitment period will be verified after the issuance of the 2022 audit report, expected by April 2023[187]. - The company has committed to ensuring that any future equity incentive policies will align with the execution of return compensation measures[167]. - The company guarantees the legality and binding nature of its commitments regarding related party transactions and competition[200].

Financial Performance - The company's revenue for Q3 2021 was CNY 112,948,127.79, representing a 0.52% increase year-over-year, while the year-to-date revenue reached CNY 393,386,649.96, a significant increase of 121.98% compared to the same period last year[3]. - The net profit attributable to shareholders for Q3 2021 was CNY 2,795,400.92, a decrease of 21.69% year-over-year, and the year-to-date net profit was CNY 18,482,277.69, down 10.70% compared to the previous year[3]. - The diluted earnings per share for Q3 2021 was CNY 0.0086, reflecting a decline of 21.82% year-over-year, while the year-to-date diluted earnings per share was CNY 0.0572, down 10.63% compared to the same period last year[3]. - Total operating revenue for Q3 2021 reached CNY 393,386,649.96, a significant increase from CNY 177,215,664.47 in Q3 2020, representing a growth of approximately 121.5%[32]. - Net profit for Q3 2021 was CNY 41,649,443.40, up from CNY 29,136,089.02 in Q3 2020, reflecting a growth of approximately 42.9%[33]. - Total comprehensive income for the period was CNY 41,649,443.40, compared to CNY 29,136,089.02 in the previous period, representing an increase of 42.9%[34]. Assets and Liabilities - The company's total assets as of September 30, 2021, were CNY 730,476,519.44, showing a slight increase of 0.42% from the end of the previous year[3]. - The total liabilities decreased to CNY 478,809,808.09 from CNY 495,566,567.31, a reduction of approximately 3.5%[30]. - The company's total equity attributable to shareholders decreased by 3.54% to CNY 91,481,537.07 compared to the end of the previous year[3]. - Current assets increased to CNY 254,798,416.82 from CNY 242,510,227.07, marking a growth of about 5.3%[28]. - The total equity was reported at 231,829,828.46, with attributable equity to shareholders at 94,835,957.54[42]. Cash Flow - The operating cash flow for the year-to-date period was CNY 57,467,008.64, an increase of 16.95% compared to the same period last year[3]. - Cash flow from operating activities decreased by 93.08% to CNY 4.86 million compared to CNY 70.30 million in the previous year, primarily due to reduced receivables[9]. - Net cash flow from operating activities was CNY 57,467,008.64, up from CNY 49,137,792.90, indicating a growth of 4.5%[37]. - The net cash flow from financing activities was negative at CNY -12,455,171.85, compared to a positive CNY 18,351,003.03 in the previous period[38]. Operating Costs and Expenses - The company's operating costs for the year-to-date period were CNY 293,988,435.45, reflecting a 116.47% increase compared to the same period last year, attributed to the manufacturing and sales of chemical products[7]. - Operating costs for Q3 2021 were CNY 343,403,694.29, compared to CNY 160,904,633.07 in the same period last year, indicating an increase of about 113.0%[32]. - Research and development expenses surged by 139.89% to CNY 12.72 million from CNY 5.30 million year-on-year, reflecting the company's focus on innovation in chemical product manufacturing[8]. - Management expenses rose by 110.07% to CNY 21.25 million from CNY 10.12 million year-on-year, indicating increased operational costs associated with the shift in business focus[8]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 17,532, with the largest shareholder holding 16.95% of the shares[10]. - The company has disclosed its shareholder structure, indicating significant holdings by individual shareholders, including Wang Jianhong with 5,028,940 shares[11]. - The major shareholders include Lanzhou Taihua Investment Holding Co., Ltd. with 54,783,700 shares and Lanzhou Asia-Pacific Industrial Group Co., Ltd. with 32,177,295 shares[11]. Investment and Financing Activities - The company reported a total debt claim of CNY 117,083,886.83 against Beijing Dashi Investment Co., including principal of CNY 70,000,000 and interest of CNY 47,083,886.83[24]. - The company made a cash payment of CNY 30 million for equity transfer during the reporting period, indicating ongoing investment activities[9]. - The company has actively pursued the recovery of CNY 3,000,000 from Beijing Lanjing Lijia Mingguang Furniture, which has ceased operations and is unable to provide timely financial data[20]. Regulatory and Compliance - The company received approval from the China Securities Regulatory Commission (CSRC) for the non-public offering on July 15, 2021[17]. - The company is preparing for the CSRC's review of its non-public offering application, indicating ongoing engagement with regulatory requirements[16]. - The company has committed to timely information disclosure regarding its non-public offering and related matters[17]. Legal Matters - The company is closely monitoring the bankruptcy proceedings of Dashi Company, as the outcome may impact future profits[25]. - The company has been involved in legal proceedings regarding the validity of resolutions related to its investments, which may affect its financial standing[23]. - The company has engaged legal counsel to assist in the preparation of claims related to its investments in Dashi Company[24].

Financial Performance - The company's operating revenue for the first half of 2021 was CNY 280,438,522.17, representing a 332.45% increase compared to CNY 64,848,759.76 in the same period last year[20]. - The net profit attributable to shareholders of the listed company was CNY 15,686,876.77, a decrease of 8.42% from CNY 17,128,340.26 in the previous year[20]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 15,249,486.07, a significant increase of 9,691.56% compared to a loss of CNY 158,988.53 in the same period last year[20]. - The net cash flow from operating activities was CNY 46,949,173.37, an increase of 434.72% from a negative cash flow of CNY 14,026,588.44 in the previous year[20]. - The total assets at the end of the reporting period were CNY 704,782,875.60, a decrease of 3.11% from CNY 727,396,395.77 at the end of the previous year[20]. - The net assets attributable to shareholders of the listed company increased by 16.54% to CNY 110,524,904.42 from CNY 94,835,957.54 at the end of the previous year[20]. - The basic earnings per share were CNY 0.0485, down 8.49% from CNY 0.0530 in the same period last year[20]. - The diluted earnings per share were also CNY 0.0485, reflecting the same decrease of 8.49% compared to the previous year[20]. - The weighted average return on net assets was 15.28%, down from 20.44% in the previous year, a decrease of 5.16%[20]. Business Operations - The main business revenue during the reporting period primarily came from the operating income of the subsidiary Cangzhou Lingang Yanuo Chemical Co., Ltd.[28]. - The company's main products include pyridine-based products, nitrated products, and other chemical products, which are primarily used in the pesticide, pharmaceutical, and feed additive sectors[28]. - The company has established a procurement model that involves direct procurement of raw materials, with a dedicated procurement department responsible for supplier management and quality assurance[32]. - The production model is based on a sales-driven approach, where production tasks are assigned based on customer orders, and safety stock is maintained for high-demand products[34]. - The company operates in the fine chemical industry, specifically focusing on pharmaceutical intermediates and pesticide intermediates, which are critical components of the chemical pharmaceutical supply chain[36]. - The fine chemical market in China has significant cost advantages over developed countries, particularly in terms of investment, raw material, and labor costs[37]. - The overall fine chemical rate in China is approximately 40%, indicating substantial room for improvement compared to the 60%-70% rates in developed economies[38]. - Nitrated products are widely used in the global pesticide market due to their low toxicity and high efficiency, making them a key raw material for new insecticides[40]. Research and Development - Research and development expenses surged by 502.12% to ¥8,740,965.99 from ¥1,451,689.32, indicating a strong commitment to innovation following a major asset restructuring[47]. - The company has developed proprietary production technologies for pyridine derivatives, including 3-cyanopyridine and 3-aminopyridine, enhancing its competitive edge in the fine chemical intermediate market[42]. - The company is focusing on research and development of new technologies to enhance product offerings and improve operational efficiency[171]. - The company is committed to research and development, allocating significant resources to innovate and improve existing product lines[173]. Environmental Compliance - The company has implemented advanced waste treatment technologies and equipment, ensuring compliance with environmental standards and enhancing its competitive advantage in sustainability[44]. - The company has established a wastewater treatment facility with a capacity of 1,000 tons per day to handle all wastewater generated from production and domestic sources[79]. - The company has implemented 14 sets of air pollution control facilities to manage emissions from production processes[79]. - The company has developed an emergency response plan for environmental incidents and conducts regular drills to ensure preparedness[80]. - The company has achieved compliance with environmental monitoring requirements, with all monitored indicators meeting discharge standards[80]. - The company has actively engaged in comprehensive waste management and environmental protection initiatives, aligning with national policies[79]. - The company emphasizes sustainability in its operations, aiming to reduce environmental impact through improved production processes and product formulations[173]. Market Risks - The company faces market risks related to the growth of the downstream pharmaceutical and agricultural industries, which could adversely affect operational performance if market expansion is below expectations[66]. - Fluctuations in raw material prices pose a risk, as they significantly impact production costs and operating profits, particularly for key materials like 3-methylpyridine and dimethyl sulfate[66]. - Environmental and safety production risks are present due to the nature of the fine chemical industry, with increasing costs associated with pollution control and potential safety incidents[66]. Corporate Governance - The company plans not to distribute cash dividends or issue bonus shares[6]. - The company has established a strict management system for related party transactions to ensure fairness and compliance with regulations[92]. - The company will not accept more favorable conditions than those offered in any fair market transaction[91]. - The company has committed to avoiding any illegal occupation of assets or funds from its subsidiaries, maintaining strict operational independence[88]. - The company has established independent financial and operational structures to ensure its autonomy and compliance with legal requirements[89]. - The company has committed to linking its compensation system to the execution of its compensation measures[103]. - The company has made a commitment to not engage in any activities that would harm its interests or those of its shareholders[103]. Legal Matters - The company is involved in a significant litigation case with a claim amount of ¥10,000,000, which is currently ongoing[157]. - The company received a civil ruling from the Beijing First Intermediate People's Court on March 15, 2021, which stated that the application for compulsory liquidation of Beijing Blue Scene Home Furniture and Building Materials Co., Ltd. was not accepted[161]. - The company is involved in ongoing litigation regarding a contract dispute with Liaoning Dongda Powder Engineering Technology Co., Ltd., with the amount in dispute being 809,800 yuan[162]. - The court ruled that the defendant, Cangzhou Lingang Yanuo Chemical Co., Ltd., must pay 787,500 yuan to the plaintiff, Liaoning Dongda Powder Engineering Technology Co., Ltd., within 15 days of the judgment becoming effective[164]. - The company has taken measures to protect its legal rights and interests in the ongoing litigation against Beijing Blue Scene Home Furniture and Building Materials Co., Ltd.[160]. - The company is actively pursuing legal actions to address the forced liquidation case against Beijing Blue Scene Home Furniture and Building Materials Co., Ltd.[161]. Future Outlook - The company has set a performance guidance for the second half of 2021, expecting continued growth in revenue and market share[172]. - The company plans to expand its market presence through strategic partnerships and new product launches in the upcoming quarters[171]. - Future guidance indicates an optimistic outlook, with projected revenue growth of 15% for the next fiscal year[171]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its product portfolio[171]. - The company is exploring new market segments to diversify its revenue streams and reduce dependency on traditional markets[172].